By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The New Orleans Employees Retirement System is suing Celera, alleging its plan to sell the company to Quest Diagnostics for $671 million undervalues the company.

Along with Celera, its CEO, Kathy Ordoñez, and its board of directors are named as defendants in the lawsuit filed in Delaware Chancery Court. Quest and its wholly owned subsidiary, Spark Acquisition, are also named as defendants.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.